LIVERMORE, Calif., Oct. 27, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), through its wholly owned subsidiary Advent Technologies S.A., is pleased to announce its official collaboration with Arxicon, a leading Greek engineering and project […]
Collaborative program with the U.S. Department of Veterans Affairs aims to validate GDNF as a first-in-class biologic for obesity and hepatic health. NEW YORK, Oct. 27, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on […]
Purpose-built for the professional user, six models available now and over 25 models expected by December. West Seneca, New York, Oct. 23, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator […]
>80% KIT knock-down and significant tumor-volume reduction in systemic mastocytosis and GIST models; GLP-validated bio analytics complete; Japan Patent protects through 2039 as IND work advances. Planned Next Steps (Near-Term): Complete GLP toxicology and CMC packages; submit […]
Margins surpassing 31%, along with 62% year-over-year topline growth to a $5MM quarter, underscore accelerating U.S. manufacturing scale and profitability before the commercialization of the next line of products: SOLIS™, COR™, and Aetherlux™ by Terravis. West Seneca, New York, Oct. 16, 2025 — Worksport Ltd. […]
Offering complete with capital overhang removed; $4.50 warrants provide future success-based capital as Worksport targets Q4 flagship launches and growth execution. West Seneca, New York, Oct. 15, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or […]
Under the new entitlement agreement, Hoth Therapeutics secures annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure, enabling advanced machine learning and neural network modeling capabilities for pharmaceutical research NEW YORK, Oct. 8, 2025 […]
Presentation to highlight advancements in Hoth’s clinical pipeline, including HT-001 for cancer-therapy-induced rash and HT-KIT, a novel oncology program targeting KIT-driven tumors NEW YORK, Oct. 7, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company […]
Winnipeg, Manitoba–October 2, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, announces that an additional 15 drill holes have been completed on the […]
Winnipeg, Manitoba– October 6, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (Snow Lake), a uranium exploration and development company, is pleased to announce that it has entered into a definitive […]
Federal Collaboration Marks Major Milestone as Worksport Targets Multi-Billion-Dollar Heat Pump Market West Seneca, New York–October 6, 2025 – Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), through its subsidiary Terravis Energy, today announced a […]
TAMPA, FL / September 30, 2025 / Wellgistics Health, Inc. (“Wellgistics Health” or the “Company”) (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced a strategic collaboration with TheracosBio, […]
B2B Revenue Grows at 25% Monthly Geometric Rate; Dealer Adoption Accelerates Ahead of HD3 and Clean-Tech Launches West Seneca, New York, Sept. 30, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based […]
LIVERMORE, Calif., Sept. 29, 2025 — (NASDAQ: ADN) Advent Technologies Holdings, Inc., through its wholly owned subsidiary, Advent Technologies, SA, is pleased to announce a new contract with Siqens GmbH, a leading German fuel cell […]
MENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but their use is often limited by severe dermatological side effects. HT-001 aims to address these […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
